LAB Stock Price Prediction 2026-2027
AI-powered forecast for Standard Biotools Inc
Based on Wall Street consensus estimate - Medium Confidence
Current Price
$0.98
Price Targets for 2027
Bear Case
$1.32
+34.8%
Base Case
$1.55
+58.6%
Bull Case
$1.78
+82.4%
Prediction Tracking
Coming Soon for LAB
Tracking begins January 2026
We are building a comprehensive track record of our AI predictions. Check back to see how our forecasts perform against actual results.
Upcoming Events for LAB
Key Factors Influencing LAB Stock
Bullish Factors
- Significant upside potential to bull case target
- Market position and competitive advantages
Risk Factors
- Declining revenue growth of -0.0%
- Market volatility and macroeconomic factors
- Competitive pressures in Life Sciences Tools & Services
Prediction Methodology
These predictions are based on the Wall Street consensus price target of $1.55.
Bull and bear cases are calculated with a reasonable spread around the consensus based on historical volatility.
Get Real-Time Analysis
Access live data, AI insights, and detailed valuations for LAB
Frequently Asked Questions
What is LAB stock price today?
LAB (Standard Biotools Inc) stock is trading at $0.98 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).
Is LAB stock going up or down today?
LAB stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.
Should I buy LAB stock now?
The decision to buy LAB depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.
Is LAB a buy, hold, or sell right now?
Our AI-powered analysis provides buy/hold/sell recommendations for LAB based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.
Is LAB stock overvalued or undervalued?
Use our DCF valuation calculator to determine if LAB is overvalued or undervalued based on fundamental analysis and future cash flow projections.
What is LAB's P/E ratio?
P/E ratio data for LAB will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.
What is LAB's market cap?
LAB (Standard Biotools Inc) has a market capitalization of $0.35 billion, making it a small-cap stock.
What is LAB's price to book ratio?
LAB trades at a price-to-book (P/B) ratio of 0.81, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.
Does LAB pay dividends?
LAB does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.
What is LAB's dividend yield?
LAB does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.
Is LAB stock a good long-term investment?
LAB's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.
What is LAB's revenue growth rate?
LAB has shown revenue growth of -0.0% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.
Is LAB profitable?
LAB is currently operating at a loss. Some companies prioritize growth over profitability in early stages. Review our financial analysis for detailed insights.
What are the risks of investing in LAB?
Key risks for LAB include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.
How does LAB compare to its competitors?
Compare LAB to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize LAB's performance and positioning.
What is LAB's stock price target for 2026?
Our AI model provides price targets for LAB based on fundamental analysis: Bull case $1.27 (+30%), Base case $1.12 (+15%), Bear case $0.88 (-10%). Visit our prediction page for detailed forecasts.
What do analysts say about LAB?
Wall Street analysts provide ratings (buy/hold/sell) and price targets for LAB. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.
When is LAB's next earnings report?
LAB reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.